SUN PHARMACEUTICAL INDUSTRIES
|
The Current P/E Ratio of SUN PHARMACEUTICAL INDUSTRIES is 38.25.
Share Price | ₹1,775.2 | Nov 19,2024 |
Market Cap | ₹425,923.7 Cr | |
Earnings-TTM | ₹11,136.5 Cr | TTM-Consolidated Results |
Price/Earnings | 38.25x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SUN PHARMACEUTICAL INDUSTRIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹425,923.7 Cr] as on Nov 19,2024
(/) Earnings [ ₹11,136.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 38.25x ]
Thus, for SUN PHARMACEUTICAL INDUSTRIES , the investors are currently willing to pay 38.25 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUN PHARMACEUTICAL INDUSTRIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SUN PHARMACEUTICAL INDUSTRIES over the last five years.
Historical PE (Price/Earnings) ratio chart of SUN PHARMACEUTICAL INDUSTRIES
PE Ratio Performance Analysis for SUN PHARMACEUTICAL INDUSTRIES
- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 41.47x.
- SUN PHARMACEUTICAL INDUSTRIES 's operated at median p/e ratio of 40.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio peaked in Mar2022 at 67.07x.
- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio hit its five-year low in Mar2020 of 22.44x.
How does SUN PHARMACEUTICAL INDUSTRIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SUN PHARMACEUTICAL INDUSTRIES | 11,136.50 | 38.25 | 425,923.7 |
CIPLA LTD | 4,485.22 | 26.49 | 118,828.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 18.73 | 101,290.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.16 | 95,280.3 |
DIVIS LABORATORIES LTD | 1,836.00 | 85.25 | 156,524.0 |
MANKIND PHARMA LTD | 2,124.86 | 48.42 | 102,890.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 58.13 | 104,742.0 |
LUPIN LTD | 2,651.94 | 35.04 | 92,929.7 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.14 | 72,478.2 |
ABBOTT INDIA LTD | 1,284.66 | 44.98 | 57,784.9 |
ALKEM LABORATORIES LTD | 2,160.96 | 30.57 | 66,062.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUN PHARMACEUTICAL INDUSTRIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.73x |
Max industry PE | 85.25x |
Median industry PE | 35.04x |
Average industry PE | 38.92x |
You may also like the below Video Courses